{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:53:13Z","timestamp":1777261993079,"version":"3.51.4"},"reference-count":87,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2861,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"2006 American College of Gastroenterology International Gastrointestinal Training Grant"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK-57892"],"award-info":[{"award-number":["DK-57892"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK-070031"],"award-info":[{"award-number":["DK-070031"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:bold>Celiac disease is a common (1% prevalence) chronic immune-mediated disorder of the small intestine induced by dietary wheat, barley, and rye. Several hepatic disorders have been described in association with celiac disease. Isolated hypertransaminasemia with nonspecific histologic changes in a liver biopsy is the commonest hepatic presentation of celiac disease. A gluten-free diet normalizes liver enzymes and histologic changes in most patients. Moreover, celiac disease can coexist with autoimmune liver disorders such as autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis. Celiac disease has increasingly been reported with a variety of other liver diseases. Thus, the hepatologist needs to consider celiac disease in the differential of abnormal liver blood tests and to be aware of the clinical implications of this frequent disease in patients with liver disorders. The possible mechanisms of liver injury and those common factors that explain the association of celiac disease with liver disorders are discussed. The aims of this article are (1) to review the spectrum and pathogenesis of liver injury related to celiac disease and (2) to provide direction to those caring for patients with chronic liver diseases regarding the detection and effective treatment of celiac disease.<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.21949","type":"journal-article","created":{"date-parts":[[2007,10,29]],"date-time":"2007-10-29T15:44:18Z","timestamp":1193672658000},"page":"1650-1658","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":161,"title":["The liver in celiac disease"],"prefix":"10.1097","volume":"46","author":[{"given":"Alberto","family":"Rubio-Tapia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-38-20241201","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJMra010852","article-title":"Celiac spruecurrent concepts.","volume":"346","author":"Farrell","year":"2002","journal-title":"N Engl J Med"},{"key":"R2-38-20241201","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/archneur.63.10.1440","article-title":"Cognitive impairment and celiac disease.","volume":"63","author":"Hu","year":"2006","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"R3-38-20241201","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1053\/j.gastro.2005.02.026","article-title":"Skin manifestations of celiac disease.","volume":"128","author":"Zone","year":"2005","journal-title":"Gastroenterology"},{"key":"R4-38-20241201","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1161\/01.CIR.0000017880.86166.87","article-title":"Celiac disease associated with autoimmune myocarditis.","volume":"105","author":"Frustaci","year":"2002","journal-title":"Circulation"},{"key":"R5-38-20241201","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1053\/j.gastro.2006.10.004","article-title":"American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease.","volume":"131","author":"Rostom","year":"2006","journal-title":"Gastroenterology"},{"key":"R6-38-20241201","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(77)90954-0","article-title":"Hepatic injury in adult celiac disease.","volume":"2","author":"Hagander","year":"1977","journal-title":"Lancet"},{"key":"R7-38-20241201","first-page":"833","article-title":"Prevalence of hypertransaminasemia in adult celiac patients and effect of glutenfree diet.","volume":"22","author":"Bardella","year":"1995","journal-title":"Hepatology"},{"key":"R8-38-20241201","first-page":"959","article-title":"Hepatic damage during celiac disease in childhood.","volume":"38","author":"Bonamico","year":"1986","journal-title":"Minerva Pediatr"},{"key":"R9-38-20241201","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(97)11222-3","article-title":"Celiac disease hidden by cryptogenic hypertransaminasemia.","volume":"352","author":"Volta","year":"1998","journal-title":"Lancet"},{"key":"R10-38-20241201","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/hep.510290318","article-title":"Chronic unexplained hypertransaminasemia may be caused by occult celiac disease.","volume":"29","author":"Bardella","year":"1999","journal-title":"Hepatology"},{"key":"R11-38-20241201","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3109\/00365529409092489","article-title":"Unsuspected celiac disease in chronic cryptogenic liver disease.","volume":"29","author":"Lindgren","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"R12-38-20241201","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cgh.2006.09.034","article-title":"Celiac disease and risk of liver disease: a general populationbased study.","volume":"5","author":"Ludvigsson","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R13-38-20241201","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/archinte.163.13.1566","article-title":"Causes of death in patients with celiac disease in a populationbased Swedish cohort.","volume":"163","author":"Peters","year":"2003","journal-title":"Arch Intern Med"},{"key":"R14-38-20241201","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1053\/gast.2002.36061","article-title":"AGA technical review on the evaluation of liver chemistry tests.","volume":"123","author":"Green","year":"2002","journal-title":"Gastroenterology"},{"key":"R15-38-20241201","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/gut.52.2.218","article-title":"Early effects of gliadin on enterocyte intracellular signaling involved in intestinal barrier function.","volume":"52","author":"Clemente","year":"2003","journal-title":"Gut"},{"key":"R16-38-20241201","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00042737-199903000-00012","article-title":"Prevalence and clinical importance of hypertransaminasemia in celiac disease.","volume":"11","author":"Novacek","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R17-38-20241201","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1590-8658(01)80014-1","article-title":"Anti tissue transglutaminase antibodies as predictors of silent celiac disease in patients with hypertransaminasemia of unknown origin.","volume":"33","author":"Volta","year":"2001","journal-title":"Dig Liver Dis"},{"key":"R18-38-20241201","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.mehy.2005.05.013","article-title":"Intestinal involvement is not sufficient to explain hypertransaminasemia in celiac disease?","volume":"65","author":"PelaezLuna","year":"2005","journal-title":"Med Hypotheses"},{"key":"R19-38-20241201","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/gut.2003.024836","article-title":"In vivo targeting of intestinal and extraintestinal transglutaminase 2 by celiac autoantibodies.","volume":"53","author":"KorponaySzabo","year":"2004","journal-title":"Gut"},{"key":"R20-38-20241201","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/01.mcg.0000170734.49725.53","article-title":"Cirrhosis in children with celiac disease.","volume":"39","author":"Demir","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"R21-38-20241201","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1053\/gast.2002.32416","article-title":"Celiac disease in patients with severe liver disease: glutenfree diet may reverse hepatic failure.","volume":"122","author":"Kaukinen","year":"2002","journal-title":"Gastroenterology"},{"issue":"pt 2","key":"R22-38-20241201","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1440-1746.2006.03296.x","article-title":"Association of celiac disease with noncirrhotic portal fibrosis.","volume":"21","author":"Sharma","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"R23-38-20241201","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3109\/00365529008997589","article-title":"Hepatic lesions in adult celiac disease.","volume":"25","author":"Jacobsen","year":"1990","journal-title":"Scand J Gastroenterol"},{"key":"R24-38-20241201","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archinte.164.2.169","article-title":"Accuracy of ultrasonography in predicting celiac disease.","volume":"164","author":"Fraquelli","year":"2004","journal-title":"Arch Intern Med"},{"key":"R26-38-20241201","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1148\/radiology.211.2.r99ma39389","article-title":"Adult celiac disease: US signs.","volume":"211","author":"Rettenbacher","year":"1999","journal-title":"Radiology"},{"key":"R27-38-20241201","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2559.1977.tb01681.x","article-title":"The liver in celiac disease.","volume":"1","author":"Pollock","year":"1997","journal-title":"Histopathology"},{"key":"R28-38-20241201","first-page":"117","article-title":"The liver in celiac disease.","volume":"37","author":"Maggiore","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R29-38-20241201","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(78)90480-4","article-title":"Primary biliary cirrhosis and celiac disease: an association?","volume":"1","author":"Logan","year":"1978","journal-title":"Lancet"},{"key":"R30-38-20241201","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00004836-199707000-00006","article-title":"High prevalence of celiac sprue among patients with primary biliary cirrhosis.","volume":"25","author":"Dickey","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"R31-38-20241201","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gut.42.1.120","article-title":"The association between primary biliary cirrhosis and celiac disease: a study of relative prevalences.","volume":"42","author":"Kingham","year":"1998","journal-title":"Gut"},{"key":"RU32-38-20241201","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1155\/2000\/934709","article-title":"Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis.","volume":"14","author":"Gillet","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"RU33-38-20241201","first-page":"248","article-title":"Dig Liver D","volume":"34","author":"Floreani","year":"2002","journal-title":"is"},{"key":"R34-38-20241201","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1111\/j.1572-0241.2002.06031.x","article-title":"Celiac disease in autoimmune cholestatic liver disorders.","volume":"97","author":"Volta","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"RU35-38-20241201","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-230X-2-5","article-title":"Primary biliary cirrhosis and autoimmune cholangitis are not associated with celiac disease in Crete.","volume":"2","author":"Chatzicostas","year":"2002","journal-title":"BMC Gastroenterol"},{"key":"RU36-38-20241201","first-page":"1524","article-title":"Screening patients with celiac disease for primary biliary cirrhosis and vice versa.","volume":"92","author":"Bardella","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"RU37-38-20241201","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1572-0241.1998.00404.x","article-title":"Gluten sensitivity in patients with primary biliary cirrhosis.","volume":"93","author":"Niveloni","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R38-38-20241201","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gut.44.5.736","article-title":"Risk of primary biliary liver cirrhosis in patients with celiac disease: Danish and Swedish cohort study.","volume":"44","author":"Sorensen","year":"1999","journal-title":"Gut"},{"key":"R39-38-20241201","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2036.2005.02328.x","article-title":"Autoimmune cholestatic liver disease in people with celiac disease: a populationbased study of their association.","volume":"21","author":"Lawson","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R40-38-20241201","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(99)80079-8","article-title":"Autoimmune cholangitis in a patient with celiac disease: a case report and review of the literature.","volume":"30","author":"Gogos","year":"1999","journal-title":"J Hepatol"},{"key":"R41-38-20241201","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s10620-006-9544-z","article-title":"Abnormal intestinal permeability in primary biliary cirrhosis.","volume":"51","author":"Feld","year":"2006","journal-title":"Dig Dis Sci"},{"key":"R42-38-20241201","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.bor.0000130538.76808.c2","article-title":"Bacterial and human autoimmunity: the case of primary biliary cirrhosis.","volume":"16","author":"Selmi","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"R43-38-20241201","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/qjmed\/hch078","article-title":"Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a populationbased cohort study.","volume":"97","author":"Watt","year":"2004","journal-title":"QJM"},{"key":"R44-38-20241201","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/ajcn\/79.4.669","article-title":"Effect of a glutenfree diet on gastrointestinal symptoms in celiac disease.","volume":"79","author":"Murray","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"R45-38-20241201","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/bmj.38169.486701.7C","article-title":"Malignancy and mortality in people with celiac disease: population based cohort study.","volume":"329","author":"West","year":"2004","journal-title":"BMJ"},{"key":"R46-38-20241201","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1023\/A:1026650118759","article-title":"Frequency and significance of antigliadin and antiendomysial antibodies in autoimmune hepatitis.","volume":"43","author":"Volta","year":"1998","journal-title":"Dig Dis Sci"},{"key":"R47-38-20241201","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jcla.20047","article-title":"High prevalence of celiac disease in autoimmune hepatitis detected by antitissue transglutaminase autoantibodies.","volume":"19","author":"Villalta","year":"2005","journal-title":"J Clin Lab Anal"},{"key":"R48-38-20241201","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM200009073431006","article-title":"The HLA system (first of two parts).","volume":"343","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"key":"R49-38-20241201","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1172\/JCI27620","article-title":"HLADQ2 and DQ8 signatures of gluten T cell epitopes in celiac disease.","volume":"116","author":"Tollefsen","year":"2006","journal-title":"J Clin Invest"},{"key":"R50-38-20241201","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis.","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"R51-38-20241201","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1089-3261(02)00055-7","article-title":"Hepatic manifestations of gastrointestinal diseases: inflammatory bowel disease, celiac disease, and Whipples disease.","volume":"6","author":"Smyth","year":"2002","journal-title":"Clin Liver Dis"},{"key":"R52-38-20241201","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-109-9-713","article-title":"Primary sclerosing cholangitis and celiac disease. A novel association.","volume":"109","author":"Hay","year":"1988","journal-title":"Ann Intern Med"},{"key":"R53-38-20241201","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004836-199601000-00020","article-title":"Primary sclerosing cholangitis with celiac sprue: two cases.","volume":"22","author":"Fracassetti","year":"1996","journal-title":"J Clin Gastroenterol"},{"key":"R54-38-20241201","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.MIB.0000161308.65951.db","article-title":"Inflammatory bowel disease in patients with celiac disease.","volume":"11","author":"Yang","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"R55-38-20241201","first-page":"1092","article-title":"Antitissue transglutaminase in inflammatory bowel disease: new evidence.","volume":"42","author":"Di Tola","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"R56-38-20241201","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1399-0039.1999.530502.x","article-title":"HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.","volume":"53","author":"Spurkland","year":"1999","journal-title":"Tissue Antigens"},{"key":"R57-38-20241201","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1080\/003655201750313441","article-title":"The HLADR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.","volume":"8","author":"Boberg","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"R58-38-20241201","first-page":"138","article-title":"Celiac sprue: another autoimmune syndrome associated with hepatitis C.","volume":"96","author":"Fine","year":"2001","journal-title":"Gastroenterology"},{"key":"R59-38-20241201","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00004836-200411000-00014","article-title":"Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome.","volume":"38","author":"DuranteMangoni","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"R60-38-20241201","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s10620-006-9360-5","article-title":"Celiac disease is not associated with chronic hepatitis C.","volume":"52","author":"Thevenot","year":"2007","journal-title":"Dig Dis Sci"},{"key":"R61-38-20241201","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-131-2-199907200-00024","article-title":"Celiac disease during interferon treatment.","volume":"131","author":"Bardella","year":"1999","journal-title":"Ann Inter Med"},{"key":"R62-38-20241201","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0140-6736(00)02880-4","article-title":"Onset of celiac disease during treatment with interferon for chronic hepatitis C.","volume":"356","author":"Cammarota","year":"2000","journal-title":"Lancet"},{"key":"R63-38-20241201","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1572-0241.2003.07652.x","article-title":"Chronic viral hepatitis, interferon, diabetes mellitus, and celiac disease.","volume":"98","author":"Narvaez","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R64-38-20241201","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1572-0241.2001.03574.x","article-title":"Interferon and ribavirin treatment of chronic hepatitis C may activate celiac disease.","volume":"96","author":"Adinolfi","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R65-38-20241201","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/1521-4141(200108)31:8<2247::AID-IMMU2247>3.0.CO;2-4","article-title":"Interferon drives T cellmediated immunopathology in the intestine.","volume":"31","author":"Monteleone","year":"2001","journal-title":"Eur J Immunol"},{"key":"R66-38-20241201","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(99)80093-2","article-title":"Ribavirin polarizes human T cell response toward a type 1 cytokine profile.","volume":"30","author":"Tam","year":"1999","journal-title":"J Hepatol"},{"key":"R67-38-20241201","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/j.1572-0241.2003.07701.x","article-title":"Hepatitis B vaccine nonresponse and celiac disease.","volume":"98","author":"Noh","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R68-38-20241201","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/MPG.0b013e3180320654","article-title":"Failure to respond to hepatitis B vaccine in children with celiac disease.","volume":"44","author":"Park","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R69-38-20241201","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1111\/j.1572-0241.2000.03403.x","article-title":"Adult celiac disease and hemochromatosis.","volume":"95","author":"Turcu","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R70-38-20241201","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1572-0241.2000.01556.x","article-title":"Precipitation of iron overload and hereditary hemochromatosis after successful treatment of celiac disease.","volume":"95","author":"Heneghan","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R71-38-20241201","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/gast.2002.34778","article-title":"The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease.","volume":"123","author":"Butterworth","year":"2002","journal-title":"Gastroenterology"},{"key":"R72-38-20241201","first-page":"1299","article-title":"Hemochromatosis gene mutations and iron metabolism in celiac disease.","volume":"89","author":"Barisani","year":"2004","journal-title":"Haematologica"},{"key":"R73-38-20241201","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease.","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"R74-38-20241201","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.dld.2004.01.012","article-title":"Searching for celiac disease in patients with nonalcoholic fatty liver disease.","volume":"36","author":"Bardella","year":"2004","journal-title":"Dig Liver Dis"},{"key":"R75-38-20241201","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1111\/j.1572-0241.2005.00244.x","article-title":"Antitissue transglutaminase antibodies in patients with abnormal liver test: is it always celiac disease?","volume":"100","author":"Loiacono","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R76-38-20241201","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM197505012921807","article-title":"Abnormalities of serum cholecystokinin and gallbladder emptying in celiac disease.","volume":"292","author":"LowBeer","year":"1975","journal-title":"N Engl J Med"},{"key":"R77-38-20241201","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0016-5085(19)33344-X","article-title":"Impaired cholecystokininpancreozymin secretion, intraluminal dilution and maldigestion of fat in sprue.","volume":"63","author":"DiMagno","year":"1972","journal-title":"Gastroenterology"},{"key":"R78-38-20241201","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0016-5085(85)90497-4","article-title":"Defective gallbladder emptying and cholecystokinin release in celiac disease. Reversal by glutenfree diet.","volume":"88","author":"Maton","year":"1985","journal-title":"Gastroenterology"},{"key":"R79-38-20241201","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1572-0241.1999.01221.x","article-title":"Gallbladder emptying and somatostatin and cholecystokinin plasma levels in celiac disease.","volume":"94","author":"Fraquelli","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R80-38-20241201","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0016-5107(99)70166-5","article-title":"Celiac disease and recurrent pancreatitis.","volume":"50","author":"Patel","year":"1999","journal-title":"Gastrointest Endosc"},{"key":"R81-38-20241201","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s00535-004-1453-3","article-title":"Obstructive jaundice caused by enteropathyassociated Tcell lymphoma in a patient with celiac disease.","volume":"39","author":"Buess","year":"2004","journal-title":"J Gastroenterol"},{"key":"R82-38-20241201","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3109\/00365529709002997","article-title":"Frequent occurrence of nonspecific gliadin antibodies in chronic liver disease. Endomysial but no gliadin antibodies predict celiac disease in patients with chronic liver disease.","volume":"32","author":"Sjoberg","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"R83-38-20241201","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/gut.49.4.506","article-title":"Guinea pig transglutaminase immunolinked assay does not predict celiac disease in patients with chronic liver disease.","volume":"49","author":"Carroccio","year":"2001","journal-title":"Gut"},{"key":"R84-38-20241201","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/00365520310000438","article-title":"High rate of positive antitissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source.","volume":"38","author":"Vecchi","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"R85-38-20241201","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cccn.2005.01.015","article-title":"False positive reactions for IgA and IgG antitissue transglutaminase antibodies in liver cirrhosis are common and methoddependent.","volume":"356","author":"Villalta","year":"2005","journal-title":"Clin Chim Acta"},{"key":"R86-38-20241201","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/CDLI.7.4.584-587.2000","article-title":"Serologic testing for celiac disease in the United States: results of a multilaboratory comparison study.","volume":"7","author":"Murray","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"R87-38-20241201","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1572-0241.2002.05471.x","article-title":"HLADQ typing in the diagnosis of celiac disease.","volume":"97","author":"Kaukinen","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R88-38-20241201","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1542-3565(05)00532-X","article-title":"Celiac disease genetics: current concepts and practical applications.","volume":"3","author":"Sollid","year":"2005","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21949","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200711000-00038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T08:10:12Z","timestamp":1733040612000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200711000-00038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21949","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1094950.549915","asserted-by":"object"}]},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}